What is the GMED stock price prediction for next 2 weeks?

According to our price prediction algorithm,Globus Medical, Inc. (GMED) price will be around $71.14 in the next 2 weeks. This means it will decrease by -15.343210758062591 from the last closing price. This prediction may vary from other time period filters for GMED stock.

What can be the highest Possible price of GMED stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, GMED can achieve the highest price of $74.87 which is -10.899772231213726 lower than last closing price. This prediction may vary from other time period filters for GMED stock.

What can be the lowest Possible price of GMED stock in next 2 weeks?

As per the forecast and algorithmic analysis, GMED stock price can be as low as $67.70 which is -19.438180578850016 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for GMED stock.

Will GMED stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that GMED stock will lose-15.343210758062591 in the next 2 weeks. This prediction may vary from other time period filters for GMED stock.

What is GMED stock last closing price?

Last closing price of GMED stock was $84.03.

What is GMED stock price prediction?

GMED stock price prediction means predicting the future closing prices of GMED stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of GMED stock in a certain time period.

How we predict GMED stock future prices?

If you are searching for GMED stock forecast, analysis or price prediction, then you might be wondering what Globus Medical, Inc. (GMED) will do in the future. Our GMED price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This GMED price prediction will likely answer most of your questions.

How frequent we update GMED stock predictions?

We are updating the forecasts for the GMED stock on daily basis.

Is using ML forecasting for GMED stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for GMED stock same for all the time periods?

No, the prediction for GMED stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Globus Medical, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$84.03-1.22%Since 2 Weeks

Predicted Price$71.14-15.34%For 2 Weeks

Upper Predicted Price$74.87-10.9%For 2 Weeks

Lower Predicted Price$67.70-19.44%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of GMED will decline by -15.34% over the next 2 Weeks and hit $71.14 by Wednesday, June 3, 2026. In that time frame, GMED's share price is expected to range between $67.70 and $74.87.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Jun 3, 2026	67.70	71.14	74.87
Jun 2, 2026	68.16	71.19	74.49
Jun 1, 2026	69.50	72.75	75.87
May 29, 2026	69.68	73.06	76.10
May 28, 2026	72.27	75.35	78.46
May 27, 2026	73.58	76.55	79.38
May 26, 2026	73.67	76.60	79.69
May 25, 2026	75.07	78.16	80.97
May 22, 2026	75.20	78.47	81.48
May 21, 2026	77.77	80.76	83.59

GMED shares rose +0.35% in Thursday, May 21, 2026's trading session, rising from a previous close of $84.03 to move at $84.33. The stock demonstrated notable intraday movement (see GMED's key stats for a full breakdown), fluctuating between $82.06 and $84.73, a +3.25% trading range. While recent weeks have seen some volatility, GMED has managed to secure a -0.88% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 2.4M shares changing hands, 319.82K more than the previous session. This amounted to $202.58M in total market activity.

Will GMED Continue Its Downward Trend?

According to analyst ratings and projections for GMED, Globus Medical, Inc. shares are anticipated to decrease by -12.63%, potentially reaching $74.87 per share by June 3, 2026. Short-term technical indicators currently suggest a neutral sentiment for GMED. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the GMED stock forecast, now is not the best time to buy GMED stock because its current trading price is +18.54% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on GMED covering social and institutional perspectives.

GMED Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into GMED's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 47.61% to 54.94%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 48.88%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 50.95%, maintains a neutral outlook for the long term. Insights into GMED's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Globus Medical Short-Term Forecasts

GMED Forecast For Next 5 Days

Our algorithm anticipates Globus Medical (GMED) stock could hit $83.58 by May 28, 2026. This represents a -0.89% rise from today's price, following a +1.34% change over the past five days.

GMED Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Globus Medical, Inc. (GMED) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $78.95, which would mean a -6.37% decrease from the current price of $84.33. Projections for this period range from a high of $90.36 to a low of $66.16.

GMED Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Globus Medical's price over the next three months point to a rise. GMED stock is expected to peak at $92.64 on Jun 16, 2026 after potentially dipping to $78.31 on May 22, 2026. On average, GMED is likely to trade around $86.93 in the coming 90 days.

Globus Medical Stock Forecast 2025

Based on our predictive models, Globus Medical (GMED) is expected to trade between $77.14 and $106.79 throughout 2026. This would result in an average price of $88.85, potentially offering investors a +5.37% return from current levels.

Globus Medical, Inc. Monthly Forecast 2026–2027

May 2026

According to our latest forecast models, Globus Medical, Inc. (GMED) is positioned to show a strong performance in May 2026. The price is predicted to move between $78.31 and $88.68, settling at an average of $83.29. This could translate to a -1.23% loss.

June 2026

Based on current market signals, Globus Medical, Inc. is projected to trend june 2026. We forecast a trading range from $81.06 to $92.64, with a likely average price of $87.54. Investors could expect a potential return of +3.81%.

July 2026

Our predictive algorithms indicate Globus Medical, Inc. stock may see a shift in July 2026. The expected range spans $82.91–$92.60, with an average target of $87.64. This represents a positive outlook and a possible gain of +3.93%.

August 2026

Analyzing established trends, Globus Medical, Inc. looks set to move in August 2026. Projections place the stock between $82.12 and $91.68, averaging around $86.64. This suggests a +2.75% gain from current levels.

September 2026

Market indicators suggest Globus Medical, Inc. could experience notable changes during September 2026. Prices could fluctuate within $83.12 to $95.60, with a midpoint forecast of $90.03. The stock might deliver a +6.77% gain.

October 2026

Forecasting for October 2026, models estimate that Globus Medical, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $77.14 and $94.51, averaging $87.47. This signals a positive trajectory with potential returns around +3.73%.

November 2026

According to our latest forecast models, Globus Medical, Inc. (GMED) is positioned to show a strong performance in November 2026. The price is predicted to move between $86.18 and $106.79, settling at an average of $92.58. This could translate to a +9.79% gain.

December 2026

Based on current market signals, Globus Medical, Inc. is projected to trend december 2026. We forecast a trading range from $86.75 to $96.66, with a likely average price of $91.81. Investors could expect a potential return of +8.88%.

January 2027

Our predictive algorithms indicate Globus Medical, Inc. stock may see a shift in January 2027. The expected range spans $86.35–$95.87, with an average target of $90.93. This represents a positive outlook and a possible gain of +7.83%.

February 2027

Analyzing established trends, Globus Medical, Inc. looks set to move in February 2027. Projections place the stock between $88.42 and $100.17, averaging around $94.52. This suggests a +12.09% gain from current levels.

March 2027

Market indicators suggest Globus Medical, Inc. could experience notable changes during March 2027. Prices could fluctuate within $85.66 to $98.10, with a midpoint forecast of $92.07. The stock might deliver a +9.18% gain.

April 2027

Forecasting for April 2027, models estimate that Globus Medical, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $91.08 and $101.45, averaging $96.34. This signals a positive trajectory with potential returns around +14.25%.

May 2027

According to our latest forecast models, Globus Medical, Inc. (GMED) is positioned to show a strong performance in May 2027. The price is predicted to move between $91.19 and $100.85, settling at an average of $96.05. This could translate to a +13.90% gain.

GMED's history of dividends and stock splits also plays a role in long-term investor confidence.